CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
10,265,714
Share change
-88,842
Total reported value
$81,402,894
Price per share
$7.93
Number of holders
32
Value change
-$704,154
Number of buys
16
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q4 2015

As of 31 Dec 2015, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,265,714 shares. The largest 10 holders included SV Life Sciences Advisers, LLC, Clarus Ventures, LLC, FMR LLC, Camber Capital Management LLC, DEERFIELD MANAGEMENT CO, Rhenman & Partners Asset Management AB, WELLINGTON MANAGEMENT GROUP LLP, FRED ALGER MANAGEMENT INC, VANGUARD GROUP INC, and BlackRock Fund Advisors. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.